01513 LIVZON PHARMA
Closed UpdateAdd to Porfolio- 39.900
- +0.200 (+0.504%)
-
- High
- 41.000
- Low
- 38.600
- Open
- 39.700
- Prev. Close
- 39.700
Main Active Buy | Main Active Sell | ||||
---|---|---|---|---|---|
Price | Turnover | Trades | Price | Turnover | Trades |
39.9 | 4,967,550 | 184 | 39.85 | 6,085,100 | 115 |
Name of Substantial Shareholder | Long Position | Short Position | Date of Relevant Event |
---|---|---|---|
UBS Group AG | 19,653,242 (7.99%) |
0 (0%) |
2018-11-16 |
Authorized Capital (M) | 300 | Share Issued (M) | 300 |
---|---|---|---|
Market Capital (M) | 11,962 | 52-Week Price High / Low |
41.850 / 23.100 |
Board Lot | 100 | Par Value | RMB 1 |
Earnings Per Share | 2.382 | P/E* (X) | 16.753 |
Dividend Per Share | 1.199 | Yield (%) | 3.005 |
Book Value | 16.177 | Price / Book NAV (X) | 2.467 |
250-Day Beta | 0.686 | Last Dividend | 0 (2025/12Q1) |
1-Month Change (%) | +38.780 | 1-Month HSI Relative (%) | +31.000 |
---|---|---|---|
3-Month Change (%) | +48.880 | 3-Month HSI Relative (%) | +33.200 |
52-Week Change (%) | +68.000 | 52-Week HSI Relative (%) | +21.800 |
1-Month Average Volume (M) |
3.120 | 3-Month Average Volume (M) |
2.069 |
10-Day MA | 35.120 | 50-Day MA | 30.385 |
---|---|---|---|
90-Day MA | 28.610 | 250-Day MA | 27.002 |
10-Day RSI | 89.34 | 14-Day RSI | 84.67 |
Code | Name | Change(%) |
---|
Code | Name | Change(%) |
---|
Code | Name | Change(%) |
---|
Code | Name | Change(%) |
---|